Abstract
The emergence of immunotherapy brings new opportunities for the treatment of LSCC. The present study aims to analyze the genomic characteristics of Chinese lung squamous cell carcinoma (LSCC) and to investigate its correlation with tissue tumor mutational burden (tTMB) and PD-L1 expression.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
